Delivery Order SPE2DR25D1022-SPE2DR26FQU6B
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of Arimidex 1 mg tablets in a 30-count package. This firm fixed-price delivery order, valued at $9,475.20, is scheduled for completion by January 12, 2026, and will be performed at the awardee's location in Conshohocken, Pennsylvania. The contract represents a non-set-aside competitive award, demonstrating the contractor's capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,097.17 to AmerisourceBergen Drug Corp for the supply of Arimidex (1 mg tablets, 30-count) on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a subsidiary of parent company...
- The Defense Logistics Agency awarded a delivery order valued at $4,483.25 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count package) on November 3, 2025, with completion scheduled for November 4, 2025. This firm fixed-price delivery order represents a non-set-aside award and is performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award reflects AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,606.55 to Amerisourcebergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packages) on January 14, 2026, with an ultimate completion date of January 15, 2026. This non-competitive, firm fixed-price delivery order will be performed at the contractor's location in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that serves...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,250.41 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) on January 7, 2026, with an ultimate completion date of January 8, 2026. This non-set-aside, firm fixed-price delivery order was competitively awarded and performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical...
- The Defense Logistics Agency awarded a $7,213.21 delivery order contract to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packaging) on December 12, 2025, with completion scheduled for December 15, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 and extends through...
- The Defense Logistics Agency awarded a $3,407.96 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Arimidex 1 mg on December 9, 2025, with completion scheduled for December 10, 2025. This firm fixed price contract, issued without set-aside designation, represents a competitively awarded order for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,894.46 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) under a firm fixed-price contract. The order was competitively awarded without a set-aside designation and is scheduled for completion by January 5, 2026. AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical delivery. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $73,658.77 to AmerisourceBergen Drug Corp for the supply of Arimidex (anastrozole) 1 mg tablets in quantities of 30 units. This firm fixed-price, competitively awarded delivery order was issued on January 13, 2026, with an ultimate completion date of January 14, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) under a firm fixed price contract valued at $5,685.12. The award was made on January 2, 2026, with an ultimate completion date of January 5, 2026, and represents a competitively awarded, non-set-aside transaction. AmerisourceBergen will perform this contract at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D1022Indefinite Delivery Contract
- SPE2DR25D1022-SPE2DR26FQU6BDelivery Order
The Defense Logistics Agency awarded a $23,687.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 15, 2026, for the supply of Arimidex 1 mg tablets in quantities of 30 units. Performance will be completed by January 16, 2026, at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, leveraging AmerisourceBergen's established presence as a major pharmaceutical distributor supporting federal medical procurement needs, particularly for military and veteran healthcare systems. This order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds the primary IDC vehicle with DLA valued at up to $999,999,999.00 through December 2031, which serves as a comprehensive global pharmaceutical support mechanism. These contracts enable delivery of a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and vaccines, to support military healthcare programs and other federal medical institutions worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.7k | 1/14/26 |